rosiglitazone has been researched along with gamma-linolenic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darwish, KM; Gomaa, MS; Helal, MA; Mostafa, S; Salama, I | 1 |
| Muralikumar, S; N Das, U; Narayanasamy, A; Vetrivel, U | 1 |
2 other study(ies) available for rosiglitazone and gamma-linolenic acid
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of novel thiazolidinediones as PPARĪ³/FFAR1 dual agonists.
Topics: Animals; CHO Cells; Cricetulus; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Molecular Docking Simulation; PPAR gamma; Receptors, G-Protein-Coupled; Thiazolidinediones | 2016 |
Probing the intermolecular interactions of PPARĪ³-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties.
Topics: alpha-Linolenic Acid; Anti-Inflammatory Agents; Arachidonic Acid; Binding Sites; Docosahexaenoic Acids; Eicosapentaenoic Acid; gamma-Linolenic Acid; Humans; Kinetics; Linoleic Acid; Linoleic Acids; Lipoxins; Molecular Docking Simulation; Molecular Dynamics Simulation; PPAR gamma; Protein Binding; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Rosiglitazone; Thermodynamics; Thiazolidinediones | 2017 |